Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that Dr. Amit Kumar, Anixa's Chairman and ...

A 2026 informational overview of GLPro's blood sugar support formula, Berberine HCL and GLP-1 research context, bariatric ...

Track Rox Hi-Tech share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss ...

Clinical trials are the engine of modern cancer care, transforming scientific discoveries into new treatments that can save ...

Cloud costs per month for enterprises and SMBs for AWS, Microsoft Azure, Google Cloud Platform, Oracle and IBM cloud ...

The Scientific Association of Botanical Education and Research today commended Johns Hopkins University for its leadership in ...

SARASOTA, Fla., March 12, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering brain-targeted therapeutics through proprietary intranasal ...

The National Institutes of Health will no longer categorize basic experimental studies involving humans (BESH) as clinical trials, according to a Jan. 29 announcement from the agency. BESH ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Abstract: Objective: Upper limb loss due to traumatic injury or disease poses significant challenges to autonomy, daily function, and workforce reintegration, profoundly impacting overall quality of ...

Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on Tuesday.